课题基金 / 基金详情

GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY: CROSS SECTIONAL STUDY

GENETIC DETERMINANTS OF ANKYLOSING SPONDYLITIS SEVERITY: CROSS SECTIONAL STUDY
强直性脊柱炎严重程度的遗传决定因素:横断面研究
批准号:
7376021
负责人:
MICHAEL H. WEISMAN
金额:
$11.03万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

MICHAEL H. WEISMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will examine associations between specific genetic markers and long-term health outcomes in patients with ankylosing spondylitis of 20 or more years. This will be done in a one time study visit to assess disease progress in terms of radiological and functional outcomes. Additionally, we will test associations between specific genetic markers and the severity of inflammation in patients with ankylosing spondylitis of 10 years or less. These patients will be monitored for 26 months to assess disease progression in terms of radiological and functional outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RHEUMATOID ARTHRITIS ASSOCIATED AUTOIMMUNITY IN HIGH RISK POPULATIONS
A COMPREHENSIVE MODEL OF SEVERITY IN OUTCOMES IN ANKYLOSING SPONDYLITIS
INFLAMMATORY MARKERS IN THE STOOL AND SERUM OF PATIENTS WITH ANKYLOSING SPONDYLI
GENETIC SUSCEPTIBILITY TO LIPID-LOWERING DRUG-INDUCED MYOPATHIES
海外基金